Biliary Tract Neoplasms
Showing 1 - 25 of >10,000
Biliary Tract Tumors Trial (Total Neoadjuvant Treatment)
Not yet recruiting
- Biliary Tract Neoplasms
- Total Neoadjuvant Treatment
- (no location specified)
Sep 7, 2023
Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)
Not yet recruiting
- Biliary Tract Diseases
- +5 more
- no interventions
- (no location specified)
Jun 1, 2023
Biliary Tract Tumors, Gallbladder Cancer, Cholangiocarcinoma Trial in Seoul (Durvalumab + Gem/Cis, Gem/Cis)
Active, not recruiting
- Biliary Tract Neoplasms
- +2 more
- Durvalumab + Gem/Cis
- Gem/Cis
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 30, 2023
Biliary Tract Tumors, Immunotherapy Trial in Beijing (Durvalumab, Lenvatinib Oral Product, Chemotherapy)
Recruiting
- Biliary Tract Neoplasms
- Immunotherapy
- Durvalumab
- +2 more
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences & Peking Union Medical Colle
Jul 6, 2023
European Training Program for Robotic Liver Surgery (LIVEROBOT)
Not yet recruiting
- Liver Diseases
- +6 more
- European Multicentre Training Program for Robotic Liver Surgery
- (no location specified)
Feb 8, 2023
Biliary Tract Cancer, Cholangiocarcinoma, Biliary Tract Tumors Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))
Recruiting
- Biliary Tract Cancer
- +2 more
- Tumor Infiltrating Lymphocytes (TIL)
-
Pittsburgh, PennsylvaniaAllyson Welsch
Jul 21, 2022
Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance Study -
Not yet recruiting
- Biliary Tract Cancer
- (no location specified)
Apr 26, 2023
Observational Monocentric Study on Biliary Tract Cancer (BABEL)
Recruiting
- Biliary Tract Cancer
-
Roma, Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli/IRCSS - UO
Jul 10, 2023
Advanced Biliary Tract Cancer Trial in Tianjin (Cadonilimab+Regorafenib+GC)
Not yet recruiting
- Advanced Biliary Tract Cancer
-
Tianjin, Tianjin, ChinaTianjin Cancer Hospital Airport Hospital
Apr 7, 2023
Postoperative Recurrence in Biliary Tract Cancers:A Multicenter
Recruiting
- Biliary Tract Cancer
- No intervention
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with NanJing Medical University
Feb 15, 2023
Advanced Biliary Tract Cancer Trial (anlotinib+TQB2450+nab-paclitaxel+cisplatin)
Not yet recruiting
- Advanced Biliary Tract Cancer
- (no location specified)
Apr 2, 2023
Biliary Tract Tumors Trial (Envafolimab plus Gemcitabine&Cisplatin, Gemcitabine&Cisplatin)
Not yet recruiting
- Biliary Tract Neoplasms
- Envafolimab plus Gemcitabine&Cisplatin
- Gemcitabine&Cisplatin
- (no location specified)
Jun 8, 2022
Advanced Biliary Tract Cancer Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)
Recruiting
- Advanced Biliary Tract Cancer
- Sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 22, 2023
Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract
Recruiting
- Biliary Tract Neoplasms
- +3 more
-
Shanghai, ChinaHuashan hospital
Aug 16, 2022
Biliary Tract Cancer Trial in Montréal (Tumour and germline molecular profiling)
Recruiting
- Biliary Tract Cancer
- Tumour and germline molecular profiling
-
Montréal, Quebec, CanadaMcGill University Health Centre
Nov 2, 2022
Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)
Not yet recruiting
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Baltimore, MarylandSKCCC Johns Hopkins
Aug 16, 2023
Advanced Biliary Tract Cancer Trial in Changsha (IBI310, sintilimab)
Not yet recruiting
- Advanced Biliary Tract Cancer
-
Changsha, Hunan, ChinaHunan cancer Hospital
Dec 13, 2022
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary
Recruiting
- Biliary Tract Cancer
- Blood drawing
-
Guangzhou, Guangdong, China
- +1 more
Dec 28, 2022
Resectable Biliary Tract Cancer Trial in Tianjin (Cisplatin, Gemcitabine, Nab-paclitaxel)
Recruiting
- Resectable Biliary Tract Cancer
- Cisplatin
- +3 more
-
Tianjin, Tianjin, ChinaTianjin Cancer Hospital Airport Hospital
Nov 30, 2022
Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seongnam-si (nab-paclitaxel plus gemcitabine-cisplatin)
Recruiting
- Biliary Tract Cancer
- +2 more
- nab-paclitaxel plus gemcitabine-cisplatin
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofCHA Bundang Medical Center
Oct 27, 2022
Bile Duct Stricture, Endoscopic Retrograde Cholangiopancreatography, Biliary Disease Trial in Beijing (Transparent cap)
Recruiting
- Bile Duct Stricture
- +3 more
- Transparent cap
-
Beijing, Beijing, ChinaThe Fifth Medical Center of Chinese PLA General Hosptial
Apr 14, 2022
Biliary Tract Cancer Trial in Changchun (Lenvatinib, PD-1 inhibitors)
Recruiting
- Biliary Tract Cancer
- Lenvatinib
- PD-1 inhibitors
-
Changchun, Jilin, ChinaLiu Bo
Aug 18, 2022
Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)
Not yet recruiting
- Biliary Tract Carcinoma
- +2 more
- Gemcitabine
- +3 more
-
Madison, WisconsinUniversity of Wisconsin
Sep 15, 2023